125 related articles for article (PubMed ID: 31250485)
1. A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion.
Masuda Y; Tsukamoto Y; Zenitani M; Oda Y; Kinoshita I; Kohashi K; Takemoto J; Hirota S; Shibata A; Koda T; Takeshima Y
Pediatr Blood Cancer; 2019 Oct; 66(10):e27902. PubMed ID: 31250485
[No Abstract] [Full Text] [Related]
2. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
[TBL] [Abstract][Full Text] [Related]
3. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.
Sokai A; Enaka M; Sokai R; Mori S; Mori S; Gunji M; Fujino M; Ito M
Jpn J Clin Oncol; 2014 Jan; 44(1):93-6. PubMed ID: 24277751
[TBL] [Abstract][Full Text] [Related]
5. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition.
Reinhart S; Trachsel Y; Fritz C; Wagner U; Bode-Lesniewska B; John H; Pless M
Urology; 2020 Dec; 146():32-35. PubMed ID: 33007314
[TBL] [Abstract][Full Text] [Related]
7. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.
Alassiri AH; Ali RH; Shen Y; Lum A; Strahlendorf C; Deyell R; Rassekh R; Sorensen PH; Laskin J; Marra M; Yip S; Lee CH; Ng TL
Am J Surg Pathol; 2016 Aug; 40(8):1051-61. PubMed ID: 27259007
[TBL] [Abstract][Full Text] [Related]
8. A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusion.
Kinoshita Y; Tajiri T; Ieiri S; Nagata K; Taguchi T; Suita S; Yamazaki K; Yoshino I; Maehara Y; Kohashi K; Yamamoto H; Oda Y; Tsuneyoshi M
Pediatr Surg Int; 2007 Jun; 23(6):595-9. PubMed ID: 17063337
[TBL] [Abstract][Full Text] [Related]
9. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
[TBL] [Abstract][Full Text] [Related]
10. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases.
Lopez-Nunez O; John I; Panasiti RN; Ranganathan S; Santoro L; Grélaud D; Wu T; Buccoliero AM; Casanova M; Alaggio R; Surrey LF
Mod Pathol; 2020 Apr; 33(4):576-590. PubMed ID: 31690781
[TBL] [Abstract][Full Text] [Related]
11. ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin.
Schoolmeester JK; Sukov WR
Int J Gynecol Pathol; 2017 May; 36(3):228-229. PubMed ID: 27636888
[No Abstract] [Full Text] [Related]
12. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
[TBL] [Abstract][Full Text] [Related]
13. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene.
Yamamoto H; Kohashi K; Oda Y; Tamiya S; Takahashi Y; Kinoshita Y; Ishizawa S; Kubota M; Tsuneyoshi M
Pathol Int; 2006 Oct; 56(10):584-90. PubMed ID: 16984614
[TBL] [Abstract][Full Text] [Related]
14. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
Ma Z; Hill DA; Collins MH; Morris SW; Sumegi J; Zhou M; Zuppan C; Bridge JA
Genes Chromosomes Cancer; 2003 May; 37(1):98-105. PubMed ID: 12661011
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Myofibroblastic Tumor Driven by Novel
Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
[TBL] [Abstract][Full Text] [Related]
16. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
17. A novel KIF5B-ALK fusion in a child with an atypical central nervous system inflammatory myofibroblastic tumour.
Maruggi M; Malicki DM; Levy ML; Crawford JR
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30344149
[No Abstract] [Full Text] [Related]
18. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
19. ALK-rearranged inflammatory myofibroblastic tumour of placental membranes.
Squires L; Matsika A; Turner J; Fitness J; Lourie R
Pathology; 2018 Dec; 50(7):777-779. PubMed ID: 30262185
[No Abstract] [Full Text] [Related]
20. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor.
Debiec-Rychter M; Marynen P; Hagemeijer A; Pauwels P
Genes Chromosomes Cancer; 2003 Oct; 38(2):187-90. PubMed ID: 12939746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]